SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors position for the imminent 80th patient event in the REGAL Phase 3 trial, with the community intensely debating the impact of a potential short squeeze amid high borrow costs and executive contract adjustments. While bullish investors point to the drug's survival data and potential buyout interest, skeptics are actively challenging the clinical validity of the control arm's performance and the trial's structural integrity.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for retail traders who are attempting to force a short squeeze through massive trading volume and collective holding. The community is actively discussing the potential for a long-term turnaround fueled by nostalgia, activist interest, and a high short interest that they believe will pressure institutional shorts into covering.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as the stock decouples from Bitcoin's performance, fueling bearish concerns regarding its capital structure, dilution, and the sustainability of its debt-fueled acquisition model. While some investors view current price levels as an accumulation opportunity, others are actively shorting the stock, citing the breakdown of the company's net asset value premium and potential risks to its dividend-paying preferred securities.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is facing significant volatility as market participants debate the durability of the geopolitical de-escalation following the recently signed memorandum of understanding between the U.S. and Iran. While official reports suggest increased tanker traffic and supply normalization through the Strait of Hormuz, the community remains deeply divided, with many traders expressing skepticism about the peace deal's long-term sustainability and citing heavy short interest as a potential catalyst for a violent price reversal.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently a central focus for investors betting on AI-driven data center energy requirements, with the stock seeing significant volatility tied to Russell index rebalancing and institutional re-rating. The community remains divided between those viewing the rapid price surge as an overvalued bubble and long-term bulls who believe the company's fuel cell technology is an essential bottleneck solution for massive, energy-constrained AI infrastructure buildouts.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment for the S&P 500 is being heavily influenced by shifting geopolitical narratives, specifically reports of a de-escalation between the U.S. and Iran ahead of market hours. Community discourse remains deeply divided between traders anticipating a holiday-week rally and those skeptical of these recurring weekend headlines, which many view as artificial market manipulation.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors aggressively rotate capital into healthcare leaders, driven by positive clinical data for its next-generation obesity treatments and strategic pipeline diversification. The community is actively discussing the stock's massive institutional momentum and its continued leadership in the GLP-1 sector as it sustains a position among the market's elite trillion-dollar valuations.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing intense volatility and speculative fervor as investors reprice the stock amidst a broader memory and storage supercycle driven by explosive AI infrastructure demand. Community sentiment is sharply divided between believers in a structural long-term growth trajectory and skeptics warning of a parabolic bubble fueled by retail FOMO and extreme technical overextension.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is experiencing heightened volatility and community debate as investors speculate on potential short-squeeze opportunities fueled by its high short interest and AI-driven credit lending model. Discussions are polarized, with many retail participants expressing frustration over the stock's recent underperformance relative to other fintech peers while others remain bullish on long-term growth and institutional accumulation.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential Russell 1000 index inclusion and closely monitor significant options activity, driving a standoff between bullish momentum and short sellers. The community remains fixated on the stock's long-term commercial potential, viewing recent price action and volume surges as a reaction to impending catalysts, despite warnings to exercise caution regarding market volatility and index-related narratives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scotiabank Raises PT on Datadog (DDOG) Stock

Scotiabank Raises PT on Datadog (DDOG) Stock...

Adobe vs. Datadog: Which Technology Stock Is a Better Buy in 2026?

Key PointsAdobe maintains a massive cash flow profile and dominant position in the creative and document software markets...

Datadog (DDOG) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Datadog (DDOG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Datadog vs. Cisco: Which Observability Stock is the Better Buy?

DDOG and CSCO are capitalizing on rising observability demand through product expansion, AI innovation and growing customer adoption.


Here's How Much $100 Invested In Datadog 5 Years Ago Would Be Worth Today

Datadog (NASDAQ:DDOG) has outperformed the market over the past 5 years by 4.33% on an annualized basis producing an average annual return of 16.36%. Currently, Datadog has a market capitalization of $79.10 billion.read more...

Can Observability Consolidation Create a Larger Opportunity for DDOG?

Datadog's observability consolidation strategy is deepening customer adoption and expanding its role across cloud, security, data and AI workloads.

Datadog (DDOG) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Datadog (DDOG) stood at $222.75, denoting a -1.71% move from the preceding trading day.

Datadog, Inc. (DDOG) Is a Trending Stock: Facts to Know Before Betting on It

Datadog (DDOG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Why Is Datadog Stock Gaining Monday?

Datadog (DDOG) stock surges as Truist upgrades to Buy with a $300 price target, citing massive enterprise AI demand. Read more.read more...

This Datadog Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday

Wall Street analysts upgraded RKLB, FLY, DDOG, and PAYX stocks with higher price targets. Check out other analysts' views on these stocks.read more...

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog’s Agentic AI Push Wins Wall Street Support – Analysts See More Upside For DDOG Stock

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$239.77
Prev Close	$220.94
Open	$224.94
Dividend Yield	0.00%
50-Day Moving Average	$197.44
Beta	1.41
Avg. Volume	7.14M
PE Ratio	639.90

52-Week High	$278.71
52-Week Low	$98.01
Market Capitalization	$85.35B
EPS (Annual)	$0.2964
Price to Book	21.39
Revenue Per Employee	$423,105.93

Feed

News

Sentiment

Earnings

Fundamentals

Info

DDOGDatadog Inc

Latest DDOG News